Hyderabad Endovascular Clinic Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 11 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.16 Cr
- Revenue Growth -36.62%
- Profit Growth -153.51%
- Ebitda -2308.83%
- Net Worth -2.32%
- Total Assets -1.74%
About Hyderabad Endovascular Clinic
Hyderabad Endovascular Clinic Private Limited (HECPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 January 2014 and has a history of 11 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹1.16 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Koppala Vikramaditya and Rupesh Bellap serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100TG2014PTC092197
-
Company No.
092197
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Jan 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Hyderabad Endovascular Clinic?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Koppala Vikramaditya | Director | 07-Jan-2014 | Current |
Rupesh Bellap | Director | 23-Oct-2021 | Current |
Financial Performance of Hyderabad Endovascular Clinic.
Hyderabad Endovascular Clinic Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 36.62% decrease. The company also saw a substantial fall in profitability, with a 153.51% decrease in profit. The company's net worth dipped by a decrease of 2.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Hyderabad Endovascular Clinic?
Unlock access to Hyderabad Endovascular Clinic's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0
₹11.63 M
Charges Breakdown by Lending Institutions
- Siemens Financial Services Private Limited : 1.16 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
26 Nov 2014 | Siemens Financial Services Private Limited | ₹1.16 Cr | Satisfied |
How Many Employees Work at Hyderabad Endovascular Clinic?
Unlock and access historical data on people associated with Hyderabad Endovascular Clinic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hyderabad Endovascular Clinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyderabad Endovascular Clinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.